ArticleCancers2025

Serum Visfatin/eNAMPT as a Biomarker in Pancreatic and Small Intestine Neuroendocrine Tumors: A Cross-Sectional Study and Future Perspectives.

Paweł Komarnicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.